
Sign up to save your podcasts
Or
Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress.
4.5
22 ratings
Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress.
98 Listeners
286 Listeners
35 Listeners
142 Listeners
4,008 Listeners
14 Listeners
49 Listeners
131 Listeners
110 Listeners
1,980 Listeners
0 Listeners
799 Listeners
78 Listeners
5,006 Listeners
3,503 Listeners